Diabetes-Related Complications and Costs in Medicare Beneficiaries with Comorbid Rheumatoid Arthritis and Diabetes Treated with Abatacept Versus Other Targeted DMARDs

INTRODUCTION: Targeted DMARD (tDMARD) use in patients with rheumatoid arthritis (RA) and type 2 diabetes mellitus (T2DM) may increase whole-body insulin sensitivity. Evidence comparing the T2DM-related clinical and economic impact of abatacept versus other tDMARDs is limited. This study compared dif...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Vardhaman, Pulungan, Zulkarnain, Shah, Anne, Jones, Barton, Petrilla, Allison, Ferri, Leticia, Han, Xue, Michaud, Kaleb
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314491/
https://www.ncbi.nlm.nih.gov/pubmed/35604547
http://dx.doi.org/10.1007/s40744-022-00453-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314491/
https://www.ncbi.nlm.nih.gov/pubmed/35604547
http://dx.doi.org/10.1007/s40744-022-00453-w

Ejemplares similares